Skip to main content
. 2022 Aug 15;45(12):2991–2998. doi: 10.2337/dc22-0294

Figure 2.

Figure 2

Change in UACR over time in patients receiving or not receiving an SGLT2i at baseline. Mixed model with factors included treatment group, region, eGFR category at screening, type of albuminuria at screening, time, treatment-by-time interaction, log-transformed baseline value nested within type of albuminuria at screening, and log-transformed baseline value-by-time interaction as covariates. eGFR, estimated glomerular filtration rate; IQR, interquartile range; SGLT2i, sodium–glucose cotransporter 2 inhibitor; UACR, urine albumin-to-creatinine ratio.